Regulatory Affairs
ANSSI Consulting ltd provides end-to-end regulatory affairs services throughout the entire drug life cycle – from early development stage, through submission and licence approval to post-approval marketing maintenance.
ANSSI Consulting ltd provides end-to-end regulatory affairs services throughout the entire drug life cycle – from early development stage, through submission and licence approval to post-approval marketing maintenance.
We deliver projects and engagements of any size, from a few hours’ strategic advice or regulatory intelligence, to large, global, multi-year engagements. We have the expertise, scalability and global reach to respond quickly to any client request for assistance – providing a local service on a truly global basis.We are proud of the excellent reputation we have built for delivering regulatory services that are quality-focused and that we are renowned for forging collaborative relationships with client stakeholders.
Our experience covers all types of medicinal products, markets and therapeutic areas, involving small molecules, biologicals, biosimilars, ATMPs, cell therapy and gene therapy. Our highly-respected management team has decades of experience in delivering regulatory solutions and strategic guidance to a wide portfolio of clients, tackling some of the most technically challenging projects, delivering successful client outcomes that are flexible and cost-effective and that offer exceptional value to clients from both commercial and scientific standpoints.
For more information on Regulatory Affairs, please fill in the form and we will respond to you as soon as possible.